Kelly Standifer to Mice
This is a "connection" page, showing publications Kelly Standifer has written about Mice.
Connection Strength
0.099
-
Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment. Methods Enzymol. 2000; 314:90-103.
Score: 0.022
-
Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol Pharmacol. 1996 Aug; 50(2):293-8.
Score: 0.017
-
Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression. J Neurochem. 1995 Nov; 65(5):1981-7.
Score: 0.016
-
Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron. 1994 Apr; 12(4):805-10.
Score: 0.015
-
Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci. 2006 Jul 13; 7:54.
Score: 0.009
-
Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther. 2006 Jun; 317(3):1027-35.
Score: 0.008
-
Characterizing kappa3 opioid receptors with a selective monoclonal antibody. Synapse. 1996 Mar; 22(3):247-52.
Score: 0.004
-
Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol Pharmacol. 1995 Jun; 47(6):1180-8.
Score: 0.004
-
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov; 251(2):477-83.
Score: 0.003